Latest News
Angus Energy (ANGS) Shares Rallied on H1 Interim Results. What Next?
Key points: Angus Energy shares rallied higher on interim results. Investors are waiting for the firm to start exporting gas.
US Natural Gas ETF, UNG – Does It Depend Entirely On Freeport?
Key points: USG is the US Natural Gas ETF It dropped 13% yesterday on news about the delay to the Freeport LNG plant reopening For a likely number of months that Freeport
Vast Resources (VAST) Share Price Is Down 58.3% in 2022. Is It a Buy?
Key points: The Vast Resources share price has fallen by 58.3% in 2022. Yet, the mining company has achieved significant milestones.
Quoin Pharma Soars 80% Premarket – Which Way Should We Speculate?
Key points: Quoin Pharma fell 10% yesterday, jumped 80% today The big question is why such price moves on no obvious information? Only then can we decide how to trade t
Premier African Minerals Shares 5% Up On Zulu – Time To Buy In?
Key points: Premier African Minerals has announced expanded mineralisation at Zulu This is a positive for the possible profitability of the site PREM's focus on the rubi
The Valirx Share Price Edged Lower After a 36.9% Crash. Here’s Why.
Key points: The Valirx share price edged lower today after yesterday’s crash. The company’s shares crashed lower on discounted share placement.
Crypto “Wild West” To Be Target of New EU Law
Key points: New EU Law To Try To Start To Reform The Crypto World Law To Include Strong Measures Against Market Abuse And Manipulation A key EU lawmaker stated the law wil
Lamprell Suspended – An Offer Or On The Track To Zero?
Key points: Lamprell shares are suspended As we surmised before, they might go to zero Or there could be an offer for the company Lamprell (LON: LAM
Energy Transfer (ET) Stock Price Has Fallen 18.1% In June. Is It a Buy?
Key points: The Energy Transfer (ET) stock price has fallen 18.1% from its June highs. The stock is currently trading above a support zone and coul
Deepverge Shares Rallied 19% on £3M Modern Water Sales. What Next?
Key points: The Deepverge share price rallied 18.9% on the Modern Water update. Modern Water’s sales in China and the Asia pacific rose to £3m in Q
7Digital Slumps 23% And Spread Blows Out – How Wary Should We Be?
Key points: 7Digital announces year end results and interesting contract news Also, that some directors didn't reveal enough of past activities The spread is massive, ma
Quantum Blockchain (QBT) Shares Fell 11.4% on FY Losses. Is It a Buy?
Key points: The Quantum Blockchain shares plunged 11.4% on FY2021 losses. Investors ignored QBT’s multiple positive milestones to focus on losses.
Revelation Bio Stock Leaps 130% – Is The SPAC Stock Being Placed?
Key points: Revelation Bio stock is up 135% premarket There's no obvious piece of news to drive this Possibly associated with the end of the SPAC stock losk up
Exicure Stock, XCUR, When A 2100% Price Rise Is Really A 20% Fall
Key points: Exicure stock is up 2100% premarket This is the result of a reverse stock split The change in XCUR's real, not nominal, stock price might be as much as minus
The Eqtec (EQT) Share Price Has Fallen 56.2% in 2022. Can It Recover?
Key points: The Eqtec share price has fallen 56.2% in 2022. Can it recover? Yes, Eqtec shares can recover if market fundamentals improve.
Crypto Hedge Fund Three Arrows Capital into Liquidation After Loan Default
Key points: Three Arrows Capital Falls into Liquidation The Crypto Hedge Fund Had Defaulted on Loan Another Chill for the Crypto Winter and Freeze!
Open Orphan Shares Rallied 6.67% on Omicron Human Challenge Study
Key points: Open Orphan shares rallied 6.67% on Omicorn human challenge Investors cheered the contract award, as evidenced by the rally.
Aston Martin Shares Fall On Reports of Capital Raise – Should We Buy?
Key points: Rumours swirl that Aston Martin is to raise more capital This could be significantly dilutive of current equity Where does the buying point come in?
The Enterprise Products Partners (EPD) Stock Price Is Rising. Is It a Buy?
Key points: Enterprise Products Partners (EPD) stock has risen 4.82% in a week. I am hesitant to recommend a buy trade on EPD now for multiple reas
Why Akebia Therapeutics (AKBA) Stock Rallied 36.9% Despite No News
Key points: The Akebia Therapeutics (AKBA) stock rallied 36.9% despite no news. There is significant investor interest in the firm, given the buyin